Dairy product consumption and development of cancer: an overview of reviews.
cancer
dairy
dairy products
overview of reviews
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
25 01 2019
25 01 2019
Historique:
entrez:
21
2
2019
pubmed:
21
2
2019
medline:
7
2
2020
Statut:
epublish
Résumé
To provide a comprehensive systematic overview of current evidence from pooled analyses/meta-analyses and systematic reviews (PMASRs) pertaining to dairy consumption and incident cancer and/or all-cause or cancer-specific mortality. Overview of reviews. Community setting. The unit of analysis is PMASRs. A total of 42 PMASRs was included in this overview of reviews. Any dairy product consumption (eg, milk, yogurt, etc). Primary outcome measure is development of any type of cancer. Secondary outcome measures are all-cause mortality and cancer-specific mortality. From 9693 citations identified, we included 42 PMASRs (52 study reports) published between 1991 and 2017. Thirty-one (74%) of these was pooled analyses/meta analyses, and only 11 (26%) were systematic reviews and meta-analyses. There was a wide variability in the type of study designs included within the other PMASRs, thus contributing to variable and, in instances, divergent estimates of cancer risk for several cancer subtypes. For example, only one systematic review and meta-analysis exclusively included prospective study designs. Most PMASRs were of low to moderate quality based on the Assessing the Methodological Quality of Systematic Reviews (AMSTAR) scores. The median AMSTAR score was 5 (IQR 2-7). Our overview identified conflicting evidence from PMASRs on association between dairy consumption and incident cancers or mortality. Heterogeneity in summary estimates reflected the inclusion of variable study designs and overall low methodological quality of individual PMASRs. The association between dairy consumption and cancer risk has been explored in PMASRs with a variety of study designs and of low to moderate quality. To fully characterise valid associations between dairy consumption and risk of cancer and/or mortality rigorously conducted, PMASRs including only high-quality prospective study designs are required. CRD42017078463.
Identifiants
pubmed: 30782711
pii: bmjopen-2018-023625
doi: 10.1136/bmjopen-2018-023625
pmc: PMC6352799
doi:
Types de publication
Journal Article
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e023625Informations de copyright
© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
JAMA Pediatr. 2013 Sep;167(9):788-9
pubmed: 23818041
Nutr Cancer. 2015;67(4):555-68
pubmed: 25923921
Maturitas. 2014 Mar;77(3):202-8
pubmed: 24374225
Nutrients. 2016 Feb 27;8(3):120
pubmed: 26927171
J Natl Cancer Inst. 2005 Dec 7;97(23):1768-77
pubmed: 16333032
Br J Nutr. 2016 Jul;116(1):158-66
pubmed: 27170091
Br J Cancer. 2016 Sep 27;115(7):862-5
pubmed: 27537381
Food Nutr Res. 2016 Nov 22;60:32527
pubmed: 27882862
Med Hypotheses. 2005;65(6):1028-37
pubmed: 16125328
Br J Cancer. 1993 Sep;68(3):627-36
pubmed: 8353053
Crit Rev Food Sci Nutr. 2014;54(9):1167-79
pubmed: 24499149
Onco Targets Ther. 2015 Dec 30;9:111-6
pubmed: 26766916
Nutrients. 2017 May 18;9(5):
pubmed: 28524093
Nutr Cancer. 2004;48(1):22-7
pubmed: 15203374
Eur J Clin Nutr. 2017 Feb;71(2):274-283
pubmed: 27677361
Oncotarget. 2015 Dec 15;6(40):43099-119
pubmed: 26515595
PLoS Med. 2009 Jul 21;6(7):e1000100
pubmed: 19621070
Int J Cancer. 2015 Mar 1;136(5):E359-86
pubmed: 25220842
Nutr Cancer. 2011 Nov;63(8):1263-71
pubmed: 22043867
Asia Pac J Clin Nutr. 2007;16(3):467-76
pubmed: 17704029
Br J Cancer. 2015 May 26;112(11):1816-21
pubmed: 26010500
Eur J Cancer Prev. 2005 Feb;14(1):13-9
pubmed: 15677891
Int J Cancer. 1991 May 30;48(3):395-8
pubmed: 2040535
PLoS One. 2014 Jul 09;9(7):e101728
pubmed: 25006674
Pharm Res. 2008 Sep;25(9):2097-116
pubmed: 18626751
J Natl Cancer Inst. 2002 Sep 4;94(17):1301-11
pubmed: 12208895
Am J Public Health. 2013 Sep;103(9):e31-42
pubmed: 23865702
Am J Epidemiol. 2017 Apr 15;185(8):697-711
pubmed: 28369205
Nutr Cancer. 2015;67(1):68-72
pubmed: 25298278
Nutr J. 2016 Oct 21;15(1):91
pubmed: 27765039
Am J Clin Nutr. 2004 Dec;80(6 Suppl):1710S-6S
pubmed: 15585792
Pediatr Int. 2010 Feb;52(1):33-8
pubmed: 19496976
Am J Clin Nutr. 2015 Jan;101(1):87-117
pubmed: 25527754
Ann Oncol. 2012 Jan;23(1):37-45
pubmed: 21617020
Int J Cancer. 2006 Jan 15;118(2):431-41
pubmed: 16052536
Cancer Epidemiol Biomarkers Prev. 2006 Feb;15(2):364-72
pubmed: 16492930
Nutr Cancer. 2006;55(2):141-50
pubmed: 17044768
Asia Pac J Clin Oncol. 2016 Jun;12(2):e269-79
pubmed: 24673835
Int J Cancer. 2007 Nov 15;121(10):2246-53
pubmed: 17583573
J Breast Cancer. 2015 Dec;18(4):313-22
pubmed: 26770237
J Natl Cancer Inst. 2004 Jul 7;96(13):1015-22
pubmed: 15240785
Cancer Epidemiol Biomarkers Prev. 2006 Sep;15(9):1688-95
pubmed: 16985031
Lancet. 2004 Apr 24;363(9418):1346-53
pubmed: 15110491
Nutr Res Rev. 2008 Jun;21(1):56-67
pubmed: 19079854
Urology. 2011 Dec;78(6):1298-305
pubmed: 22137695
Ann Oncol. 2014 Jun;25(6):1106-15
pubmed: 24631943
Med Hypotheses. 2001 Oct;57(4):510-4
pubmed: 11601881
Nutr Cancer. 2008;60(4):421-41
pubmed: 18584476
CA Cancer J Clin. 2017 Jan;67(1):7-30
pubmed: 28055103
Sci Rep. 2016 Feb 15;6:20624
pubmed: 26877260
Int J Epidemiol. 2002 Feb;31(1):78-85
pubmed: 11914299
Crit Rev Oncol Hematol. 2016 Apr;100:16-24
pubmed: 26921971
Nutrition. 2014 Jun;30(6):619-27
pubmed: 24800664
World J Gastroenterol. 2014 Nov 14;20(42):15879-98
pubmed: 25400475
Eur J Clin Nutr. 2003 Jan;57(1):1-17
pubmed: 12548291
Nutr Cancer. 2009;61(1):47-69
pubmed: 19116875
Med Hypotheses. 2004;62(1):133-42
pubmed: 14729019
J Clin Epidemiol. 2009 Oct;62(10):1013-20
pubmed: 19230606